*  Long-term diabetes complication: Liver inflammation raises cholesterol levels | EurekAlert! Science News
Hypercholesterolemia is a lipid metabolism disorder (dyslipidemia) characterized by an elevated cholesterol level in the blood. ... Key Role in the Maintenance of Hepatic and Systemic Lipid Homeostasis. "Our data suggest that the liver plays a key role in the ... Researchers Discover New Regulator in Glucose Metabolism https:/. /. www.. helmholtz-muenchen.. de/. en/. press-media/. press- ... In their study, the researchers focused on inflammatory processes that are known to occur in many metabolic disorders such as ...
  https://eurekalert.org/pub_releases/2017-08/hzm--ldc081417.php
*  NLMĀ® Classification 2007 Edition Now Available. NLM Technical Bulletin. 2007 Mar-Apr
Dyslipidemias was broadened to Lipid metabolism disorders.. * Various instructional notes were added or modified to clarify ...
  https://www.nlm.nih.gov/pubs/techbull/ma07/ma07_classification.html
*  Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration - Full Text View - ClinicalTrials.gov
Metabolic Disorder Hypercholesterolemia Dyslipidemias Lipid Metabolism Disorders Drug: mipomersen Drug: Placebo Phase 2 ... Metabolism, Inborn Errors. Lipid Metabolism Disorders. Infant, Newborn, Diseases. Congenital Abnormalities. ... Lipid Metabolism, Inborn Errors. Disease. Hypercholesterolemia. Dyslipidemias. Hyperlipidemias. Hyperlipoproteinemias. ... Lipid Metabolism, Inborn Errors Hyperlipidemias Metabolic Diseases Hypolipoproteinemia Hypolipoproteinemias ...
  https://clinicaltrials.gov/ct2/show/NCT00362180?cond=%22chanarin-dorfman+syndrome%22+OR+%22lipid+metabolism%2C+inborn+errors%22&rank=9
*  Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED) - Full Text View - ClinicalTrials.gov
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Vascular Diseases. Arteriosclerosis. Arterial Occlusive Diseases ... prior therapy with any statin without achieving goal (2.5 mmol/L of LDL cholesterol) at last lipid check performed ...
  https://clinicaltrials.gov/show/NCT00723723
*  Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose...
Glucose Metabolism Disorders. Metabolic Diseases. Hyperlipidemias. Dyslipidemias. Lipid Metabolism Disorders. Rosiglitazone. ... lipids, muscle and liver lipid contents, and restoring body fat distribution than either intervention alone. At baseline and ... We hypothesize that rosiglitazone will lower blood sugar, insulin, blood fats, muscle and liver lipid content and composition ... muscle and liver lipid content and composition. ...
  https://clinicaltrials.gov/show/NCT00025753?order=429
*  Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients - Full Text View - ClinicalTrials.gov
Dyslipidemias. Lipid Metabolism Disorders. Niacin. Niacinamide. Nicotinic Acids. Hypolipidemic Agents. Antimetabolites. ... which is highly effective for similar lipid disorders in the general population, may be effective in treating lipid disorders ... Additional agents for the treatment of lipid metabolism disorders in HIV-infected patients are needed. Niacin, ... Lipid disorders are common among patients with HIV and tend to worsen with potent antiretroviral therapy. Lipid-lowering drugs ...
  https://clinicaltrials.gov/show/NCT00046267?order=378
*  Effects Of Consumption Of A Highly Mineralized Sodium Bicarbonated Water On Blood Lipid Profile - Full Text View -...
lipid metabolism. Cardiovascular risk. Additional relevant MeSH terms: Hypertriglyceridemia. Hyperlipidemias. Dyslipidemias. ... With personal history of anorexia nervosa, bulimia or eating disorders;. *With a body weight variation , 5 kg in the last 3 ... Eating foodstuffs or dietary supplements that may interfere with lipid metabolism (red yeast rice, policosanol, omega-3 fatty ... Using of medications which could affect lipid absorption or/and metabolism (long-term corticosteroid treatment); ...
  https://clinicaltrials.gov/ct2/show/NCT01819636?recr=Open&intr=%22Minerals%22&rank=7
*  A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications - Full Text View - ClinicalTrials.gov
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Skin Diseases, Metabolic. Skin Diseases. Protease Inhibitors. ...
  https://clinicaltrials.gov/show/NCT00002417?order=46
*  Effects of Acipimox on Mitochondrial Function in Obesity - Full Text View - ClinicalTrials.gov
Glucose Metabolism Disorders. Metabolic Diseases. Hyperlipidemias. Dyslipidemias. Lipid Metabolism Disorders. Acipimox. ... Change in tibialis intramyocellular lipid (IMCL) normalized to creatinine is given.. *Change From Baseline in Lipid Profile at ... Nutrition Disorders. Overweight. Body Weight. Signs and Symptoms. Hyperinsulinism. ... Change From Baseline in Intramyocellular Lipid Content at 6-months [ Time Frame: Change from Baseline to 6-months ]. ...
  https://clinicaltrials.gov/ct2/show/NCT01488409
*  Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels - Full Text View -...
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Hydroxymethylglutaryl-CoA Reductase Inhibitors. ... Patients diagnosed with dyslipidemia and taking or planning to take statin treatment. Patients living in the same city of the ... Patients with dyslipidemia who are taking or planning to take a statin treatment (Atorvastatin, Fluvastatin, Prevastatin, ... Available Lipid Profiles of Compliant and Non-compliant Participants [ Time Frame: Month 12 ]. Available laboratory ...
  https://clinicaltrials.gov/ct2/show/NCT00673660
*  Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or...
Dyslipidemias. Lipid Metabolism Disorders. Skin Diseases, Metabolic. Skin Diseases. Fenofibrate. Niacin. Niacinamide. ... Glucose Metabolism Disorders. Metabolic Diseases. Arteriosclerosis. Arterial Occlusive Diseases. Vascular Diseases. ... The collaborative team has expertise in lipid and lipoprotein metabolism, innovative and effective diet modification programs, ... Triglycerides (mg/dL): Fasting lipid levels. *Non-HDL-C [ Time Frame: Measured at 24 weeks ]. non-HDL-C (mg/dL): Fasting lipid ...
  https://clinicaltrials.gov/show/NCT00246376?order=205
*  Antihyperlipidemic Effects of Oyster Mushrooms - Full Text View - ClinicalTrials.gov
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Hypolipidemic Agents. Antimetabolites. Molecular Mechanisms of ... pilot study in 20 subjects to determine if there are detectable lipid-lowering effects of oyster mushrooms in patients with HIV ...
  https://clinicaltrials.gov/show/NCT00069524?order=37
*  The Health Access and Recovery Peer Program - Full Text View - ClinicalTrials.gov
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. To Top. *For Patients and Families ... bipolar disorder, major depression, obsessive-compulsive disorder, or post-traumatic stress disorder ... Presence of a serious mental illness (schizophrenia, schizoaffective disorder, ...
  https://clinicaltrials.gov/ct2/show/NCT01725815?term=High+cholesterol+OR+hyperlipidemia&recr=Open&fund=01&rank=11
*  Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients...
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Ezetimibe. Antibodies, Monoclonal. Anticholesteremic Agents. ... Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab ... Drug: Alirocumab Drug: Placebo (for alirocumab) Drug: Ezetimibe Drug: Placebo (for ezetimibe) Drug: Lipid Modifying Therapy ( ... Alirocumab 75 mg every 2 weeks (Q2W) and oral placebo capsule for ezetimibe daily added to stable Lipid Modifying Therapy (LMT ...
  https://clinicaltrials.gov/ct2/show/study/NCT01644188?term=%22High+Cholesterol%22&lup_s=05%2F11%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14&show_locs=Y
*  Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients - Full Text View - ClinicalTrials.gov
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Ritonavir. Lopinavir. Rosuvastatin Calcium. HIV Protease ... evaluation of lipid lowering activity on week 0,4,8,12. *endothelial function will be measured at week 0 & 12 (optional for ... To determine the effect of rosuvastatin on plasma lipids, lipoproteins, and endothelial function in HIV-infected patients on ... history or current condition that might interfere with absorption,distribution metabolism or excretion ...
  https://clinicaltrials.gov/show/NCT00184951?order=35
*  GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound - Full Text View -...
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. To Top. *For Patients and Families ... Subjects not taking lipid-regulating therapy must enter the study via a lipid stabilization period. Subjects who are intolerant ... at week 78 than placebo in adults with coronary artery disease taking lipid lowering therapy. ...
  https://clinicaltrials.gov/ct2/show/NCT01813422?term=%22Coronary+Artery+Disease%22&lup_s=05%2F05%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14
*  Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia - Full...
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Rosuvastatin Calcium. Fenofibrate. Anticholesteremic Agents. ... Although the combination of statin and fenofibrate is one of the options for patients with combined hyperlipidemia, non-lipid ... Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia. ...
  https://clinicaltrials.gov/ct2/show/NCT01414803
*  Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis - Full Text...
Dyslipidemias. Lipid Metabolism Disorders. Fenofibrate. Hypolipidemic Agents. Antimetabolites. Molecular Mechanisms of ... Glucose Metabolism Disorders. Metabolic Diseases. Embolism and Thrombosis. Vascular Diseases. Cardiovascular Diseases. ... Fasting and postprandial lipids and lipoproteins after a standarized test meal.. *Fasting and postprandial oxidized fatty acids ...
  https://clinicaltrials.gov/show/NCT00422396
*  Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia - Full Text View - ClinicalTrials.gov
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Rosiglitazone. Hypoglycemic Agents. Physiological Effects of ... Lipid levels particularly serum triglycerides are increased. HDL, the 'good cholesterol' is decreased. Higher than normal level ... It has also been noted to improve blood lipid levels. Rosiglitazone works by stimulating the PPAR gamma system. It is hoped ...
  https://clinicaltrials.gov/show/NCT00006493?order=22
*  Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia - Full Text View - ClinicalTrials.gov
Dyslipidemia. Additional relevant MeSH terms: Hypercholesterolemia. Hyperlipidemias. Dyslipidemias. Lipid Metabolism Disorders ... Elevated plasma cholesterol (hypercholesterolemia) and various other plasma lipid imbalances (dyslipidemias) are major risk ... affecting lipid metabolism.. *Has a positive hepatitis B surface antigen, or hepatitis C virus antibody, as determined by ... Additional lipid risk factors designated by Adult Treatment Panel III include elevated triglycerides, elevated non-high density ...
  https://clinicaltrials.gov/ct2/show/NCT00868127
*  Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia - Full Text View...
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Pravastatin. Anticholesteremic Agents. Hypolipidemic Agents. ... Treatment with lipid-lowering drugs, unless they can be withdrawn within the following time frame prior to the first qualifying ... Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia. This study has ... Lipid-Lowering Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia. ...
  https://clinicaltrials.gov/ct2/show/NCT00245388
*  Cholesterol and Pharmacogenetic Study - Full Text View - ClinicalTrials.gov
Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Vascular Diseases. Arteriosclerosis. Arterial Occlusive Diseases ... Measurements of plasma lipids and lipoproteins, as well as other markers of cardiovascular disease risk, were obtained at the ... Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS One. 2010 Mar 22;5(3):e9763. ... Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin. Arterioscler Thromb Vasc ...
  https://clinicaltrials.gov/ct2/show/NCT00451828?term=cholesterol&rank=17